4//SEC Filing
MORNEAU MICHAEL 4
Accession 0001209191-18-034494
CIK 0001607678other
Filed
May 30, 8:00 PM ET
Accepted
May 31, 7:03 PM ET
Size
4.8 KB
Accession
0001209191-18-034494
Insider Transaction Report
Form 4
MORNEAU MICHAEL
Chief Financial Officer
Transactions
- Sale
Common Stock, par value $0.00001 per share
2018-05-31$9.25/sh−21,551$199,347→ 94,035 total
Footnotes (1)
- [F1]All 21,551 of the shares were acquired on May 18, 2018 pursuant to the Issuer's 2014 Employee Stock Purchase Plan.
Documents
Issuer
Viking Therapeutics, Inc.
CIK 0001607678
Entity typeother
Related Parties
1- filerCIK 0001517780
Filing Metadata
- Form type
- 4
- Filed
- May 30, 8:00 PM ET
- Accepted
- May 31, 7:03 PM ET
- Size
- 4.8 KB